Irene Agodoa - Concepedia

Author

Irene Agodoa

Amgen (United States)

Also Known As

Agodoa, Irene, I Agodoa, I. Agodoa, I. L. Agodoa, Irene AGODOA, Irene Agodoa, Irene L. Agodoa

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)Global Blood Therapeutics (United States)Oregon Health & Science University Optum (United States)St. Jude Children's Research Hospital

About

Irene Agodoa is an author at Amgen (United States) specializing in medicine, osteoporosis, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	579
2	Health Policy	2	2	61
3	Health Sciences	1	1	20
4	Public Health	1	1	33
5	Geriatrics	1	1	33

Irene Agodoa

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Burden of Illness for Osteoporotic Fractures Compared With Other Serious Diseases Among Postmenopausal Women in the United States Andrea Singer, Alex Exuzides, Leslie Spangler, Mayo Clinic Proceedings Bone DiseaseSkeletal TraumaBone HealthOsteoporotic Fractures ComparedMedicine	2014	336
Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease Deborah P. Lubeck, Irene Agodoa, Nickhill Bhakta, JAMA Network Open	2019	308
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial Jo Howard, Kenneth I. Ataga, Robert C. Brown, The Lancet Haematology Sickle Cell DiseasePediatric HematologyLong-term Follow-up ResultsHematologyTranslational Research	2021	99
Rates and Predictors of 30-Day Readmission Among Commercially Insured and Medicaid-Enrolled Patients Hospitalized With Systolic Heart Failure Larry A. Allen, Karen E. Smoyer Tomic, David M. Smith, Circulation Heart Failure	2012	72
Association of anemia correction with health related quality of life in patients not on dialysis Marcus Alexander, Reshma Kewalramani, Irene Agodoa, Current Medical Research and Opinion	2007	60
Patient-Reported Outcomes in Chronic Heart Failure Mitchell A. Psotka, Robyn von Maltzahn, Milena Anatchkova, JACC Heart Failure Heart FailureChronic Heart FailureCardiovascular DiseaseOutcomes ResearchCardiac Care	2016	49
The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type Larry A. Allen, Karen E. Smoyer Tomic, Kathleen Wilson, Journal of Medical Economics	2012	40
Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective Stuart L. Silverman, Irene Agodoa, Morgan Kruse, Journal of Osteoporosis Cost-effectiveness AnalysisPharmacotherapyOrthopaedic SurgeryOsteoporosisBone Disease	2015	33
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis Nirmish Shah, Thokozeni Lipato, Ofelia Álvarez, Expert Review of Hematology	2022	33
Dialysis patients treated with Epoetin alfa show improved anemia symptoms: A new analysis of the Canadian Erythropoietin Study Group trial Paul Keown, David Churchill, Melanie Poulin-Costello, Hemodialysis International	2010	29

Page 1